Biotechnology News

July 31, 2012

SAN ANTONIO--(BUSINESS WIRE)--GenSpera approved by FDA to initiate G-202 PhaseII trial in prostate cancer.

July 31, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma, Inc., a specialty pharmaceutical company, today announced the appointment of Robert Rosen to its board of directors.

July 31, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Affymax, Inc. (Nasdaq: AFFY) today announced that it will host a teleconference and webcast with management to provide a general business overview, as well as to discuss its second quarter 2012 financial...

July 31, 2012

SAN FRANCISCO--(BUSINESS WIRE)--Fibrosis Platform and Pipeline Attracting Broad Interest from Pharmaceutical and Mid-to-Large Biotech Organizations

July 31, 2012

SAN FRANCISCO--(BUSINESS WIRE)--CytomX Therapeutics Expands Series B Financing; Canaan Partners Joins Syndicate

July 31, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Tuesday, August 7, 2012, at 8:30 a.m. ET. During the call, management will provide an update on Infinity's business and discuss the...

July 31, 2012

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Theorem Clinical Research has relocated its headquarters 1.5 miles from the original site in King of Prussia, Pa., where the company has been located for the past ten years.

July 31, 2012

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE):   ($ in millions, except per share amounts)     Second-Quarter     Year-to-Date 2012     2011(4)     Change 2012     2011(4)     Change Reported Revenues $ 15,057 $ 16,485 (9%) $ 29,942 $ 32,509...

July 31, 2012

HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) today reported second quarter 2012 financial results. Adjusted net income increased $28.4 million to $41.0 million in the second quarter 2012, or $0.60 per diluted share,...

July 31, 2012

ALACHUA, Fla.--(BUSINESS WIRE)--RTI Biologics, a leading provider of orthopedic and other biologic implants, reported operating results for the second quarter of 2012.

July 31, 2012

LIMERICK, Pa.--(BUSINESS WIRE)--Teleflex Reports Second Quarter 2012 Results

July 31, 2012

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/htww9f...

July 31, 2012

LINKÖPING, Sweden--(BUSINESS WIRE)--Regulatory News: As at July 31, 2012, the number of shares in Sectra AB (STO:SECTB) amounts to 74,189,956, of which 5,241,384 are Series A and 68,948,572 are Series B. This entails an increase of 37,094,987 in...

July 30, 2012

LIMERICK, Pa.--(BUSINESS WIRE)--Teleflex Announces European Market Clearance for its Innovative Vascular Access Catheter

July 30, 2012

MORRISVILLE, N.C.--(BUSINESS WIRE)--Furiex Pharmaceuticals Announces Closing of Priligy® Asset Transfer and License Agreements

July 30, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced the submission of a New Drug Application (NDA) for its investigational BCR-ABL inhibitor, ponatinib, to the U.S. Food and Drug Administration (FDA)....

July 30, 2012

SEATTLE--(BUSINESS WIRE)--July 30, 2012--Dendreon Corporation (NASDAQ:DNDN) today reported results for the quarter ended June 30, 2012. Net product revenue for the quarter was $80.0 million compared to $48.1 million for the quarter ended June 30...

July 30, 2012

SEATTLE--(BUSINESS WIRE)--July 30, 2012--Dendreon Corporation (Nasdaq:DNDN) today announced a strategic restructuring plan designed to accelerate the Company’s path to profitability and future growth. The plan includes re-configuring Dendreon’s...

July 30, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology, Inc. (Nasdaq: CLVS) will announce its second quarter 2012 financial results on Wednesday, August 8, 2012, before the open of the U.S. financial markets. Clovis’ senior management will host a...

July 30, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Announces Positive Results from Viral Kinetic Study of the Nucleotide Analogue ALS-2200 in People with Hepatitis C

July 30, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals 2Q 2012 Earnings and Business Update Conference Call Invitation: Conference Call Scheduled for 8:00 AM EDT, Tuesday, August 7th

July 30, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that company management will discuss Cubist’s business activities and financial outlook at investor conferences during August 2012. On Wednesday,...

July 30, 2012

LUTZ, Fla.--(BUSINESS WIRE)--CytoDyn (OTCQB:CYDY) Agreement to Acquire PRO 140 from Progenics Pharmaceuticals

July 30, 2012

BOSTON--(BUSINESS WIRE)--Leading healthcare investment bank Leerink Swann today announced that Thomas Bassinger has recently joined the Firm’s Investment Banking group as a Managing Director, reporting to James Boylan, Head of Investment Banking...

July 30, 2012

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Cannabis Science (OTCBB:CBIS), a pioneering U.S. Biotech Company developing pharmaceutical products for global public health challenges is pleased to report on the continued progress made by Patient Three...

July 30, 2012

FORT WAYNE, Ind.--(BUSINESS WIRE)--EXTENSION, INC. announced 159% second quarter 2012 revenue growth over the same period in 2011 and added 26 new hospitals to its healthcare customer list.

July 30, 2012

CHICAGO--(BUSINESS WIRE)--The Illinois Biotechnology Industry Organization and Georgia Bio have joined the Advanced Medical Technology Association’s (AdvaMed) State Medical Technology Alliance (SMTA).

July 30, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq: XNPT) announced today that it will release its second quarter financial results on August 7, 2012 at approximately 4:30 p.m. Eastern Time. The company will host a conference call at 5:...

July 30, 2012

MILAN--(BUSINESS WIRE)--Consolidated results for the second quarter of 2012: Revenues were €188.2 million; Net profit was €7.4 million; Free cash flow● was €37.4 million; Sorin Group estimates that the negative impact on revenues, net profit and...

July 30, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Elekta (STO:EKTAB) announced that collaboration with Brainlab has resulted in the integration of Brainlab’s ExacTrac® patient positioning system in its Elekta radiation therapy machines. Two Elekta...

July 30, 2012

TAMPA, Fla. & MINNEAPOLIS--(BUSINESS WIRE)--Biovest is seeking EU approval for BiovaxID, its personalized cancer vaccine, and the EMA has designated the Rapporteur and Co-Rapporteur for the planned MAA submission.

July 30, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--New Health Economics report suggests that for best results, HOL team managers should determine the ideal set of activities for HOLs and decide which structural alignment will help team meet goals.

July 30, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida announces tech evaluation agreement for Tethadur protein/antibody delivery system with leading biopharmaceutical company

July 30, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Several recent pharma deals include collaborations in which different companies contribute drugs to the development or testing of a potential combination regimen, according to Decision Resources.

July 30, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Announces Availability of ZETONNA™ for the treatment of allergic rhinitis. The only dry nasal aerosol approved by U.S. FDA with once daily, one spray per nostril dosing.

July 30, 2012

CHARLOTTE, N.C.--(BUSINESS WIRE)--Hospitals, healthcare providers to benefit from new Premier agreements for RFID asset tracking and management solutions

July 30, 2012

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen Ltd. (NASDAQ: CGEN) today announced that the Company will host a conference call at 10:00 AM EDT on Tuesday, August 7, 2012 to review second quarter 2012 results. The quarterly results will be released...

July 30, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis reports updated Phase 2 trial data

July 30, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, today announced treatment of the final patient in the first patient cohort in its Phase 1/2 clinical trial...

July 30, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--When pharmaceutical companies organize their best-performing health outcomes liaison (HOL) teams, decision makers pay careful attention to where the group sits and how it is structured.

July 30, 2012

SAN DIEGO--(BUSINESS WIRE)--Assay Depot partners with AstraZeneca to launch a private virtual laboratory, a cloud-based software that is customized to support AstraZeneca R&D, empower researchers and promote innovation.

July 30, 2012

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading stem cell company focused on developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets...

July 30, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it has earned a development milestone payment from GlaxoSmithKline (GSK), totaling $3.2 million. The...

July 30, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care solutions, today announced the U.S. Food and Drug Administration (FDA) has...

July 30, 2012

NETANYA, Israel--(BUSINESS WIRE)--Octopus successfully completed the initial biomechanical testing phase, simulating spinal annular repair during "worst case" biomechanical loading scenarios

July 30, 2012

HENDERSON, Nevada--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced it was named...

July 30, 2012

PHOENIX--(BUSINESS WIRE)--At the Microscopy & Microanalysis (M&M) 2012 Annual Meeting, Bruker today announced the Dimension FastScan Bio™ Atomic Force Microscope (AFM), which enables high-resolution microscopy research in biological...

July 30, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for cabozantinib as a treatment for patients with...